Chemical Compound

BKM 120; 5-(2,6-di-4-Morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-pyridinamine; NVP-BKM 120

CAS Registry Number 944396-07-0
BKM 120; 5-(2,6-di-4-Morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-pyridinamine; NVP-BKM 120 结构式
Primary record

BKM 120; 5-(2,6-di-4-Morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-pyridinamine; NVP-BKM 120

库存
5,432 克
纯度
98.5 %
CAS
944396-07-0

化合物标识与属性

CAS
944396-07-0
PubChem CID
16654980
SMILES
C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4
Canonical SMILES
Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1

名称与同义词

  • Buparlisib
  • 944396-07-0
  • NVP-BKM120
  • BKM120
  • NVP-BKM-120
  • BKM-120
  • buparlisibum
  • Buparlisib [INN]
  • 5-(2,6-dimorpholinopyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine
  • BKM 120
  • Buparlisib (BKM120)
  • NVP-BKM 120
  • Buparlisib [USAN:INN]
  • 3sd5
  • BKM-120NX
  • BKM120-NX
  • Buparlisib (USAN/INN)
  • RefChem:570492
  • 0ZM2Z182GD
  • BUPARLISIB [USAN]
  • UNII-0ZM2Z182GD
  • BKM 120NX
  • MFCD18251596
  • D01QSO
  • PI3K Inhibitor BKM120
  • 1202777-78-3
  • C18H21F3N6O2
  • BKM120-AAA
  • BUPARLISIB [WHO-DD]
  • QCR-4
  • CHEMBL2017974
  • cc-258
  • MLS006010984
  • SCHEMBL146956
  • DTXSID50241486
  • BKM120 (NVP-BKM120, Buparlisib)
  • CWHUFRVAEUJCEF-UHFFFAOYSA-N
  • GTPL7878
  • orb1307367
  • BKM120,NVP-BKM120
  • SCHEMBL29350945
  • SCHEMBL29351351
  • SCHEMBL29387968
  • AMMD00049
  • CHEBI:71954
  • CTK8C0567
  • 944396-07-0 (free base)
  • BKM-120 (PI3K)
  • BMK-120
  • DTXCID50163977
  • EX-A189
  • SYN1200
  • GLXC-90108
  • HMS3295I15
  • HMS3655D16
  • AOB87379
  • BKM120 (NVP-BKM120)
  • BKM120 - NVP-BKM120
  • ABP000735
  • AN2025
  • ANW-64908
  • BDBM50380363
  • NSC754353
  • NSC799370
  • s2247
  • ZINC43154039
  • AKOS016005372
  • ACN-031536
  • AM85983
  • BCP9001011
  • CCG-264954
  • CS-0089
  • DB11666
  • EBC-220039
  • FD64903
  • NSC-754353
  • NSC-799370
  • RL05935
  • SB16577
  • SDCCGSBI-0654414.P001
  • Buparlisib (BKM120, NVP-BKM120)
  • 5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine
  • NCGC00262604-01
  • NCGC00262604-08
  • 4CA-0929
  • AC-32077
  • AC-35575
  • AK103313
  • AN-26178
  • AS-40568
  • BC638775
  • BKM120 (NVP-BKM120, Buparlisib)?
  • CID:16654980
  • HY-70063
  • SMR004702786
  • SY078482
  • 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-Pyridinamine
  • SID:160778579
  • AB0008183
  • AJ-108243
  • DB-079882
  • ST2411649
  • TC-153653
  • A3015
  • FT-0755923
  • NS00072516
  • SW218149-2
  • X7578
  • J3.281.564B
  • KS-00000637
  • A11016
  • A25436
  • D10584
  • W-5735
  • 5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine
  • 5-[2,6-Di(Morpholin-4-Yl)pyrimidin-4-Yl]-4-(Trifluoromethyl)pyridin-2-Amine
  • A892274
  • C571178
  • BRD-K42191735-001-01-2
  • BRD-K42191735-001-05-3
  • BRD-K42191735-001-08-7
  • Q25100534
  • 5-[2,6-bis(morpholin-4-yl)pyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine
  • Buparlisib, 98%, a selective PI3K inhibitor - 1G 1g
  • B0084-438224
  • 2-Pyridinamine, 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-
  • 2-Pyridinamine,5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-
  • 4-(trifluoromethyl)-5-(2,6-dimorpholinopyrimidin-4-yl)pyridin-2-amine
  • 5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine.
  • 2,4-Bismorpholino-6-[4-(trifluoromethyl)-6-aminopyridin-3-yl]pyrimidine
  • 2-Amino-4-(trifluoromethyl)-5-[2,4-bismorpholinopyrimidine-6-yl]pyridine
  • 4-(Trifluoromethyl)-5-(2,6-dimorpholino-4-pyrimidinyl)-2-pyridineamine
  • 4-Trifluoromethyl-5-(2,6-di(4-morpholinyl)-4-pyrimidinyl)pyridine-2-amine
  • 5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine
  • (4-Trifluoromethyl-5-[2,4-di(4-morpholinyl)pyrimidine-6-yl]pyridin-2-yl)amine
  • 5-(2,6-di-morpholin-4-yl-pyrimidin-4-yl)-4-trifluoromethyl-pyridin-2-ylamine
  • BKM 120; 5-(2,6-di-4-Morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-pyridinamine; NVP-BKM 120
  • SD5